Compound class
SARMs
Selective androgen receptor modulators and related compounds.
SARMs are selective androgen receptor modulators. Ostarine is a nonsteroidal SARM,1 and LGD-4033 (ligandrol) is an oral one that binds the androgen receptor.2 An FDA warning letter calls products one seller marketed as SARMs unapproved new drugs, says life-threatening reactions, including liver toxicity, have occurred in people taking products containing SARMs, and says SARMs have the potential to increase the risk of heart attack and stroke.3 The WADA 2026 list names andarine, ostarine, ligandrol, RAD140, S-23 and YK-11 as prohibited SARMs.4
SARMs and related compounds 8
-
Andarine (S-4)
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Cardarine
PPARδ agonist
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
LGD-4033 (Ligandrol)
- Half-life
- 24 to 36 hours
- Given
- Once daily in studies
- Form or status
- No product label among its sources
-
Ostarine (MK-2866)
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
RAD-140 (Testolone)
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
S-23
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
SR-9009 (Stenabolic)
Rev-ErbA agonist
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
YK-11
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
Guides 6
- How to take cardarine: what sources sayWhat human trials of cardarine (GW501516) gave by mouth and for how long, plus its approval status and the gaps on liquids and storage.
- Ligandrol dosage: what sources sayLGD-4033 doses and schedules in two human trials, what internet capsules and tablets contained, and what the FDA says about SARMs.
- Ostarine dosage: what studies usedOstarine (enobosarm) doses and schedules in phase 2 and 3 trials, what online products contained, storage, and what regulators say.
- RAD 140 dosage: what sources sayIn twenty-two women with metastatic breast cancer, the phase 1 trial gave 50 mg, 100 mg or 150 mg once daily; 100 mg/day was its maximum tolerated dose.
- SR-9009 dosage: what sources sayNo label or human trial gives an SR-9009 dose. What regulators, product analyses and mouse studies report, and how the product's storage is stated.
- YK-11 dosage: what sources sayNo label or human trial found gives a YK-11 dose. What the horse and rat studies used, what is sold, regulator and WADA status, and what is unknown.
References 4
- Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. 2011. PMC3177038
- Basaria S, Collins L, Dillon EL, Orwoll K, Storer TW, Miciek R, Ulloor J, Zhang A, Eder R, Zientek H, Gordon G, Kazmi S, Sheffield-Moore M, Bhasin S. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci 2013;68(1). PMC4111291
- US Food and Drug Administration. Dynamic Health Group dba SARMS AMERICA - 719257 - 12/12/2025 | FDA. 2025. fda.gov
- World Anti-Doping Agency. World Anti-Doping Code International Standard Prohibited List 2026. 2026. wada-ama.org
Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.